Biogen Receives Health Canada Authorization for ZURZUVAE™ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada

Biogen Canada Inc. today announced that Health Canada has issued a Notice of Compliance (NOC) for ZURZUVAE™ (zuranolone) for ...

Global Skin Health Supplement Market Forecast: USD 2.57 Billion in 2025 to USD 4.62 Billion by 2035 -- Future Market Insights, Inc. Report

Future Market Insights (FMI), the global provider of market intelligence and strategic advisory solutions, today announced ...